ArticleCancer research2018

Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3-NANOG Axis.

Se Jin Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.